VLXC - Veltex Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.2300
-0.0200 (-8.00%)
At close: 11:48AM EST
Stock chart is not supported by your current browser
Previous Close0.2500
Open0.2496
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2299 - 0.2496
52 Week Range0.0610 - 0.2500
Volume4,100
Avg. Volume21,654
Market Cap16.894M
Beta (5Y Monthly)0.33
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Veltex Corporation Announces the Appointment of Luba Andrus, RPh., M.J. to the Board of Directors

    CHICAGO, Aug. 5, 2019 /PRNewswire/ -- Veltex Corporation – OTC Markets symbol (VLXC) Veltex Corporation ("Veltex") announces the appointment of Luba Andrus, RPh., M.J. to the Board of Directors. Luba Andrus has more than 30 years of executive, operational, and retail leadership experience in both the pharmaceutical and cannabis industries, including owning co-founder and principal of two medical marijuana dispensaries in Illinois. Prior to entering the medical cannabis industry, she owned and operated numerous retail pharmacies which were ultimately sold to a Resurrection hospital system.

  • PR Newswire

    Veltex Corporation Announces the 2019 Annual Meeting of Shareholders

    CHICAGO, May 13, 2019 /PRNewswire/ -- Veltex Corporation-- OTC Markets symbol (VLXC) Veltex Corporation announces the 33rd Annual Meeting of Shareholders will be held on Thursday July 25, 2019 at The Wynn Hotel and Resort in Las Vegas, Nevada. The property is located at 3131 South Las Vegas Boulevard, Las Vegas, Nevada 89109, USA Telephone 1-702-770-7000. Only shareholders of record may attend the Annual Meeting.

  • PR Newswire

    Veltex Corporation Announces Dr. Harry L. Haroutunian, MD Joins Board of Directors

    CHICAGO, April 23, 2019 /PRNewswire/ -- Veltex Corporation -- OTC Markets symbol (VLXC) Veltex Corporation ("Veltex") announces that Dr. Harry L. Haroutunian, MD  has joined the Veltex Board of Directors effective immediately. Veltex President and CEO Andreas Mauritzson commented, "We are very excited to welcome Dr. Haroutunian to our board who is the foremost expert in the field of addiction treatment and brings with him deep knowledge, extensive relationships and a unique approach to recovery. Dr. Haroutunian will be a cornerstone to Veltex's highly anticipated entry into the $25 billion health and wellness business.